WEBEROVÁ, Dana, Pavel WEBER, Hana MATĚJOVSKÁ KUBEŠOVÁ and Hana MELUZÍNOVÁ. Treatment of pulmonary embolism of 260 in-patients of acute medical department in the elderly. In Congress of the Clinical Section IAGG-ER. 2012.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Treatment of pulmonary embolism of 260 in-patients of acute medical department in the elderly
Authors WEBEROVÁ, Dana (203 Czech Republic, guarantor, belonging to the institution), Pavel WEBER (203 Czech Republic, belonging to the institution), Hana MATĚJOVSKÁ KUBEŠOVÁ (203 Czech Republic) and Hana MELUZÍNOVÁ (203 Czech Republic, belonging to the institution).
Edition Congress of the Clinical Section IAGG-ER, 2012.
Other information
Original language English
Type of outcome Requested lectures
Field of Study 30200 3.2 Clinical medicine
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/12:00063465
Organization unit Faculty of Medicine
Keywords (in Czech) pozdní stáří - plicní embolizace - hluboká žilní trombóza - diagnostika - terapie - rizikové faktory - antikoagulační terapie
Keywords in English Advanced age – pulmonary embolism (PE) – deep venous thrombosis (DVT) – diagnostics – therapy – risk factors – anticoagulant therapy
Tags International impact, Reviewed
Changed by Changed by: MUDr. Dana Weberová, učo 144201. Changed: 27/4/2014 09:40.
Abstract
The retrospective analysis of the database of inpatients with the target assess the clinical course of PE according to prevalence, mortality, average duration of stay, risk factors, used diagnostic methods and kinds of therapy. Another aim of the study was a comparison of the dates among the survivors and deceased persons. We found the most important risk factors in the group of the deceased immobility (p<0.001)` heart failure (p<0.005) and stroke (p<0.01). On the contrary in the survivor group there were more frequent risk factors obesity (p<0.025); deep venous thrombosis (p<0.025) and tumors (p<0.05). Previous operations and traumas in the last month did not show any significant difference between both groups. Used treatment methods were evaluated, too. In the group of those who died predominated multi-morbidity, often frailty and geriatric giants even if the anticoagulant therapy was used comparably in both groups (survivors and the deceased).
PrintDisplayed: 4/9/2024 06:22